PE risk stratification: which tool is best?


    PE risk stratification: which tool is best?


    Your patient with a newly diagnosed PE hates hospitals.  He or she agrees to defer to your judgement about admission versus discharge home, but makes it clear they would prefer to go home if it is safe.  Which tool should you use to help you decide?

    Up until recently, there were no prospective studies comparing sPESI (simplified pulmonary embolism severity index) and Hestia, the leading risk stratification tools for PE.  Finally, in August 2018 (see reference below), a single center, prospective cohort study including 488 patients newly diagnosed with PE was published that compared the two scores head to head.

    Reassuringly, both scores identified similar numbers of low risk patients (sPESI 28%, Hestia 27%).  Interestingly, interobserver reliability was better with sPESI than with Hestia (disagreement in 1.2% patients versus 7.6% patients, respectively).  When looking at what criteria each score takes into consideration, this result makes sense because Hestia contains more subjective criteria (see below).

    The bottom line is that both scores identified similar numbers of low risk patients, but sPESI may have more interobserver reliability than Hestia.






    Hestia Criteria:


    CHEST 2016 guidelines for PE:



    Accuracy and interobserver reliability of the simplified pulmonary embolism severity index versus the hestia criteria for patients with pulmonary embolism. Acad Emerg Med. 2018 Aug 29. doi: 10.1111/acem.13561.

    Antithrombotic Therapy for VTE Disease.  Kearon, Clive et al., CHEST, Volume 149, Issue 2, 315 – 352.


    • Welcome! This is the website for the Mount Sinai Emergency Ultrasound Division. It serves as an information resource for residents, fellows, medical students and others seeking information about point-of-care ultrasound. There is a lot ofRead more

    • Reach for the COWS

      Your patient in intake is miserable. Doubled over, complaining of pain everywhere, sweating, ill-appearing but not unstable. He tells you that the last time he used heroin was two nights ago, and he is askingRead more

    • Tis the season, summer edition

      As the late spring rains have begun to fade and the temperature rises mercilessly into the 80s and beyond, summer is finally upon us. And with summer comes a host of diseases for the emergencyRead more

    • Meet the newest member of your team

      We have a new resource in the Sinai ED. Say hello to your friendly ED pharmacist. In the past several years, the ED pharmacy has been centralized in a non-ED location. We all know wellRead more

    • In the spirit of roasts and fire-breathing dragons

      You’re on a lovely amble through the backcountry when suddenly you see smoke rising nearby and catch a whiff of a familiar scent that throws you back to your med school OR days: burning flesh.Read more

    • E-point Septal Separation in the Patient with Congestive Heart Failure

      Perhaps never explained so clearly, Cisewki and Alerhand’s article on EPSS is a wonderful read. Bottom line to remember: EPSS > 7 mm was 87% sensitive and 75% specific at identifying reduced EF (<50%).  This isRead more

    • Lidocaine for cough?

      Whether it’s asthma, a U.R.I., or post nasal drip as the cause, cough is a common enough complaint encountered by emergency physicians everywhere. Of course you must always rule out the dangerous causes of coughRead more

    • Measles redux!

      A quick search of for the keyword measles brings up a solitary post from 2015, and it’s not actually about measles. With all the attention that measles has been getting in the news recently,Read more

    • The Apple Watch Heart Study

      Disclosure: I’m a huge Apple Fan. Unless you’ve been living under a rock, you’ve heard about the Apple watch, many of you reading this are wearing one right now. On April 24th, 2015 it joinedRead more